Batey R, Scott J, Jain S, Sherlock S
Scand J Haematol. 1979 Mar;22(3):277-9. doi: 10.1111/j.1600-0609.1979.tb02809.x.
A patient of 14 years suffering from secondary haemosiderosis and thalassaemia major was treated with i.v. desferrioxamine in doses up to 3 g/d. Urine iron loss ranged from 46-158 mg/d. Despite improvement in cardiac and hepatic status the patient developed acute renal insufficiency of the pre renal type. The possible role of desferrioxamine in this complication is discussed. Desferrioxamine given s.c. or i.v. effects a marked urinary iron loss but its use may not be without significant complications.
一名14岁患有继发性血色素沉着症和重型地中海贫血的患者接受了静脉注射去铁胺治疗,剂量高达3克/天。尿铁丢失量在46 - 158毫克/天之间。尽管心脏和肝脏状况有所改善,但患者仍出现了肾前型急性肾功能不全。讨论了去铁胺在这种并发症中的可能作用。皮下或静脉注射去铁胺可导致显著的尿铁丢失,但其使用可能并非没有重大并发症。